Study design
This study employed a prospective open labelled randomized controlled design for which CONSORT guidelines have been used (Fig 1 Study Flow Diagram), focusing on individuals presented with low Bone Mineral Density (BMD) and symptomatic indications of bone loss, characterized as Symptoms of bone degeneration. The investigation was carried out at Sumatibhai Shah Ayurved Mahavidyalaya, Hadapsar, Pune -28 an urban private hospital and research centre situated in Pune, Maharashtra in academic year 2021-2022. The research period includes various steps like drug authentication, trial drug standardization and analysis, dose preparation, Pre assessment, enrolment, drug distribution, periodic follow ups and post assessment of Participants at the end of study.
Participants were aged between 40 to 60 years with BMD (right heel) falling within the range of 1 to 2.5 standard deviations below the mean, as measured using a portable Calscan device (CM 300 Ultrasound Bone Densitometer) were assessed for bone health using a carefully designed and validated questionnaire. Subsequently, eligible individuals were enlisted and equally randomized into distinct study groups. Initial BMD measurements were recorded and subsequent assessments were conducted on the 60
th day of the intervention. Concurrently, evaluations of bone health were performed at intervals spanning 0, 15, 30, 45 and 60 days within both intervention and control groups.
Randomization
A cohort of 150 female participants aged 40 to 60 years, regardless of religious, marital, occupational, or socio-economic conditions, were pre-screened for eligibility based on study criteria. Anticipating a 20% attrition rate, 86 eligible subjects were retained for inclusion. Subsequently, these subjects were equally randomized into either the intervention (43 participants) or control group (43 participants). Randomization was adapted through a lottery method without replacement. The process of allocation concealment involved sequentially numbered opaque and sealed envelopes entrusted to an investigator not directly engaged in the study’s implementation.
Blinding: This was an open-label trial; neither participants nor investigators were blinded to group allocation.
Sample size calculation
The sample size was estimated assuming a 20% difference in BMD improvement, 80% power, 5% significance level, accounting for a 20% dropout rate.
Inclusion criteria
1. Age: Between 40 to 60 years.
2. Gender: Female
3. Bone Mineral Density: Falling within 1 to 2.5 standard deviations below the mean of young adults.
Exclusion criteria
Participants presenting the following attributes were excluded from the study:
1. Known cases of hypertension or cardiovascular diseases.
2. Individuals with compromised endocrine function such as hyperthyroidism or parathyroidism.
3. Subjects with documented cases of irritable bowel syndrome, gluten intolerance, or other gastrointestinal absorption disorders.
4. Participants with a history of prolonged corticosteroid therapy.
5. Individuals with a prior history of one or more fractures stemming from falls or minor impacts.
Intervention
Participants in the experimental group were administered Wheat extract, coupled with a regimen of dietary and lifestyle modifications. On the other hand, subjects in the control group received a calcium supplement integrated with dietary and lifestyle adjustments over the course of 60 days.
Wheat extract as intervention
Wheat powder (Godhum Churna) in the treatment of fractures (Asthibhagna Chikitsa)
Prominent
Ayurvedic texts, including
Charaka Samhita, S
ushruta Samhita,
Ashtanga Hridaya,
Ashtanga Sangraha,
Bhavaprakasha Nighantu,
Madanapala Nighantu and Shaligram Nighantu, emphasize the tissue binding
“Sandhaniya” quality of Wheat.
Acharya Yogratnakara and
Chakradatta expound on the utilization of Wheat powder in the treatment of fractures
(Asthibhagna Chikitsa).
(Sasthri, 2017).
Similarity between wheat and bone tissue
The human bone’s anatomical composition consists of periosteum (outermost layer), osteons housing Haversian systems, compact bone, cancellous bone forming a mesh-like structure and finally the medullary cavity. Analogously, wheat features a rigid pericarp, seed coats, starchy endosperm arranged from outer to inner layers. Drawing parallels, the outer layers of wheat can be compared to the periosteum, while the starchy endosperm mirrors cancellous bone.
Ayurvedically, substances with
“Pathya” attributes possess the capacity to augment a tissue (
Dhatu) structurally resembling each other. (Trikamaji J, editor.
Charaka Samhita of Charaka and Dridhabala, with Ayurveda Dipika commentary, Reprint ed.; 2011).
Acharyas advocate the properties of tissue binding (
Asthisandhan), unctuousness
(Snigdha), augmentation
(Bruhana) and strengthening (
Balya) for Wheat. According to
Chakarapanidatta, tissue binding is a characteristic of a substance that fosters restoration. Therefore, Wheat emerges as an auspicious candidate for bolstering bone health, encompassing both structural and functional facets.
(Trikamaji, 2011).
Selection of Khapali godhum for intervention
In this study,
Triticum dicoccum (Khapali Godhum) is employed, resembling the
Nandimukhi variety in appearance and qualities endorsed as Wholesome
(Pathyakara) by
Bhavaprakasha Nighantu,
Kaiyadeva Nighantu and Madanapala Nighantu.
Triticum dicoccum is a traditional species of wheat distinguished by its desirable texture, enhanced taste and elevated nutritional content. It serves as a robust source of dietary fibers, proteins and carbohydrates, containing total carbohydrate content ranging from 78.7% to 83.2%.
Classical Reference to wheat in powder in the treatment of fractures
Acharya Yogratnakara significantly explained the utilization of wheat powder as a therapeutic agent in the context of fracture treatment
(Sasthri, 2017).
Selection of extract form (Satva kalpana)
The
Triticum dicoccum exhibited an appropriate overall carbohydrate content for the preparation of Extract, a process generally applied to herbs with higher starch content. This approach significantly enhances the therapeutic efficiency of the substance, reduces the therapeutic dosage required, prolongs the drug’s shelf life and introduces a novel perspective on employing dietary substances as medicinal agents. In the present study, the
Bhavaprakasha-prescribed method for
Guduchi Satva Nirman Vidhi was followed as per guideline for the preparation of Wheat extract, as no definitive classical method for preparing Wheat extract was available.
Classical concept of Sandhana
Acharya Chakrapani Datta describes tissue binding as preventing loss and promoting storage.
It is conducive to joining and healing.
Dalhanacharya and
Acharya Vagbhata highlight that substances aiding in bone healing are
Sandhaniya. Evidently,
Sandhaniya implies “that which heals fractures.”
(Trikamaji, 2011). These attributes align with the restoration and prevention of tissue depletion
(Dhatu Kshaya), which is pivotal in countering bone degeneration.
Probable mode of action of Godhuma satva
In cases of exacerbated
Vata due to factors causing tissue depletion
(Dhatukshaya),
Vata tends to occupy vacant cell pores
(Strotas), exacerbating the condition.
Wheat’s sweet taste (
Madhura Rasa), unctuousness (
Snigdha), strengthening quality (
Balya Guna) and post-digestive effect (
Madhura Vipaka) might counterbalance this aggravated
Vata, rectifying osteoporosis
(Trikamaji, 2011).
Acharya Kashyapa’s assertion aligns, as balanced
Doshas foster
Dhatu nourishment.
Wheat extract’s potential action involves mitigating excessive bone resorption through
Vata pacification and addressing calcium and vitamin D requirements.
Outcome measures
Primary outcome - Change in Bone Mineral Density (BMD) at 60 days.
Secondary outcome - Change in bone degeneration (
Asthikshaya Lakshana) questionnaire scores at 15, 30, 45 and 60 days.
Statistical analysis
The data generated from the study was subjected to statistical analysis Performed using SPSS Version 20.0. Missing data handled by excluding incomplete records, categorized into two distinct segments:
1. Analysis of demographic data of study subjects.
2. Analysis of assessment parameters.
I. Objective criteria
1. Paired t-test: To assess the efficacy within both Group A and Group B.
2. Unpaired t-test: To ascertain the mean differences and establish efficacy comparisons between the two groups.
II. Subjective criteria
1. Wilcoxon signed rank test: Utilized to assess efficacy within Group A and Group B.
2. Mann whitney U test: To facilitating the determination of significance and comparison between Group A and Group B.